SGGP
In order to ensure there is enough medicine to treat patients with hand, foot and mouth disease in the context of this increasing epidemic, the Drug Administration of Vietnam ( Ministry of Health ) and pharmaceutical businesses are making efforts to find a source of medicine to treat hand, foot and mouth disease.
Following the import of 6,000 bottles of immunoglobulin infusion solution imported by Duy Anh Pharmaceutical Trading Company Limited in June, it is expected that this week, Central Pharmaceutical Joint Stock Company CPC1 will import an additional 3,000 bottles of immunoglobulin infusion solution out of a total of 15,000 bottles that have been licensed for import.
The import is now ready, depending only on arranging flights as soon as possible. For injectable drugs containing the active ingredient Phenobarbital, the Drug Administration has granted a license to Central Pharmaceutical Joint Stock Company CPC1 to import 21,000 vials of the drug and this amount of drug has been brought to Vietnam.
According to the Ministry of Health , in the first 7 months of the year, the country recorded about 35,000 cases of hand, foot and mouth disease, compared to the same period in 2022, the number of cases decreased by 9.7%. However, the number of deaths increased by 15 cases, while in the same period last year there were 3 cases.
Source
Comment (0)